Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
6,716.09
(
0.00%
)
US TECH 100
24,029.60
(
-0.43%
)
Dow Jones
46,993.26
(
0.00%
)
Brent Oil
104.67
(
3.99%
)
Bitcoin
72,544.50
(
-1.90%
)
News Focus
News Focus
Post# of 257253
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

genisi

Send PM Follow Ignore
Followers 28
Posts 5148
Boards Moderated 0
Alias Born 05/24/2006

genisi

Re: DewDiligence post# 88581

Thursday, 01/07/2010 7:32:08 AM

Thursday, January 07, 2010 7:32:08 AM

Post# of 257253

I would think that GS9350 would need to show superiority to ritonavir in some respect for it to supplant ritonavir as the PI-boosting agent of choice in HIV.

You think that if it is at least as good and safe boosting agent as ritonavir, it won't be enough for the quad-pill?
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Trade Smarter with Thousands

Leverage decades of market experience shared openly.

Join Now